Short interest in CARISMA Therapeutics Inc (NASDAQ:CARM) decreased during the last reporting period, falling from 558.58K to 554.17K. This put 1.66% of the company's publicly available shares short.

Short interest for CARISMA Therapeutics gives investors a sense of the degree to which investors are betting on the decline of CARISMA Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 136.89K shares traded per day, it would take 4.05 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.